Safety and feasibility of carotid artery stenting in patients with coexisting carotid and coronary artery disease
10.3760/cma.j.issn.0253-3758.2013.07.013
- VernacularTitle:颈动脉支架术治疗颈动脉狭窄合并冠心病患者的可行性和安全性
- Keywords:
Carotid stenosis;
Coronary disease;
Stents
- From:
Chinese Journal of Cardiology
2013;41(7):577-582
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the safety and feasibility of carotid artery stenting (CAS) for treating patients with coexisting carotid and coronary artery disease.Methods The clinical data of 237 consecutive patients [(66.1 ± 7.7) years old,79.7％ male] with coexisting carotid and coronary artery disease undergoing CAS in Fuwai hospital from January 2005 to June 2010.The patients were analyzed retrospectively.Indication for CAS was defined as carotid artery diameter reduction of ＞ 60％ (symptomatic) or ＞ 80％ (asymptomatic) with suitable carotid artery anatomy for stenting.Thirty-day rates of stroke,death and myocardial infarction after CAS were assessed.Results All patients suffered from coronary artery disease,of whom 87 (36.7％) had unstable angina pectoris and 82 (34.6％) had recent myocardial infarction (＜ 30 days).The procedural success rate of CAS was 99.2 ％ (235/237).Cerebral protection devices were used in 234 patients (99.6％).Among them,36 (15.2％) patients received simultaneous bilateral CAS and 79 (33.3％) patients underwent simultaneous percutaneous intervention of other noncoronary arteries.Within 30 days after CAS,127 (53.6％) patients underwent coronary revascularization,including 118 (49.6％) coronary artery bypass grafting and 9 (3.8％) percutaneous coronary intervention.The rate of major stroke,minor stroke,death and myocardial infarction from time of CAS to 30 days was 2.1％ (5/237),3.0％ (7/237),0.4％ (1/237) and 0.4％ (1/237) respectively.Conclusion Data from this study indicate that CAS is safe and feasible for treating patients with coexisting carotid and coronary artery disease with a low incidence of periprocedural complication rate.
